Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma

    Tag: pharma

    You Searched For "pharma"
    Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study

    Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study

    Farhat Nasim20 April 2019 10:00 AM IST
    The drug, tanezumab, belongs to a new category of pain medications that target nerve growth factor, a protein involved in the growth of nerve cells,...
    Government to revise limit of free salicylic acid content in drugs containing ASPIRIN

    Government to revise limit of free salicylic acid content in drugs containing ASPIRIN

    Meghna A Singhania18 April 2019 3:13 PM IST
    New Delhi: Government is soon going to revise the limit of free salicylic acid content in medicines containing Aspirin, as the Drugs and Techincal...
    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Garima18 April 2019 10:15 AM IST
    If the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), under the Ministry of AYUSH goes through the proceeds, would add to...
    Adverse Reactions: Cefotaxime, Oflaxicin, Cefixime told to carry Warning by CDSCO

    Adverse Reactions: Cefotaxime, Oflaxicin, Cefixime told to carry Warning by CDSCO

    Meghna A Singhania17 April 2019 12:26 PM IST
    New Delhi: The national regulatory body for Indian Pharmaceutical and Medical Device, Central Drugs Standard Control Organisation (CDSCO) has ordered...
    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Farhat Nasim17 April 2019 9:45 AM IST
    Zydus Cadila Group Chairman Pankaj R Patel said this innovation has the potential to bring about a paradigm shift in the management of CKD patients...
    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Meghna A Singhania16 April 2019 4:47 PM IST
    Alchem's molecule is the sole micronized digoxin available globally that resolves the challenge of micro dosage formulation and the long-term...
    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Garima16 April 2019 9:40 AM IST
    Pulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Farhat Nasim15 April 2019 10:05 AM IST
    Bimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
    Suven Life Sciences gets US court nod to buy assets of Rising Pharmaceuticals

    Suven Life Sciences gets US court nod to buy assets of Rising Pharmaceuticals

    Farhat Nasim14 April 2019 10:00 AM IST
    "This court approval brings closure to the sale process for Rising Pharmaceuticals and paves the way for a seamless transition of the portfolio,...
    Deloitte, Google Cloud to collaborate on transformative solutions for health care

    Deloitte, Google Cloud to collaborate on transformative solutions for health care

    Garima13 April 2019 9:35 AM IST
    New Delhi: Deloitte and Google Cloud recently announced plans to collaborate on next-generation solutions for the life sciences and health care to...
    Sandoz to commercialize Rizmoic to treat opioid-induced constipation

    Sandoz to commercialize Rizmoic to treat opioid-induced constipation

    Farhat Nasim13 April 2019 9:21 AM IST
    HOLZKIRCHEN: Sandoz recently announces that it has signed an agreement with Shionogi & Co Ltd for commercialization of Rizmoic (naldemedine) in...
    Ranbaxy Case: Singh Brothers diverted funds despite SC orders, alleges Daiichi

    Ranbaxy Case: Singh Brothers diverted funds despite SC orders, alleges Daiichi

    Medical Dialogues Bureau12 April 2019 2:30 PM IST
    "Their nearly Rs 6,300 crore has been syphoned off by some 'baba'. These children have been duped," Kapil Sibal had said, adding that let the...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok